1 minute read

INVESTING FOR BETTER HEALTH

Advertisement

Through the direction of resources and capital flows, investors have a pivotal role to play in fostering healthcare innovation to weather future challenges. Notably, The Bridgespan Group identifies healthcare as the secondlargest sector in terms of impact investing potential, presenting an opportunity for investors to make a real difference by supporting the growth of healthcare companies. At ARCHIMED, we have been convinced of the crucial role healthcare companies play in sustaining humanity’s wellbeing and have witnessed their tremendous contribution but also the potential risks emerging from poor control and management. As an impact investor, we intend to guide healthcare actors towards building resilient and equitable healthcare systems, supporting access to a healthy life. Over the last 20 years, our leadership team has directly managed and invested in over 80 small to large-size healthcare companies globally, representing over €50 billion of combined value.

Alongside superior financial returns, our funds target investments that seek to generate a positive and measurable social impact on human, animal, and environmental health in line with our corporate mission to improve health outcomes for all. Following our impact investment strategy, ARCHIMED’s newest funds, MED III and MED PLATFORM II (MP II) have as a sustainable investment objective to contribute to the Sustainable Development Goal “Good health and well-being” (SDG 3) and ARCHIMED’s Health Objectives. Beyond private equity, ARCHIMED has a direct impact on health outcomes by committing 5% of carried interest from all funds annually to the EURÊKA Foundation, founded by ARCHIMED in 2014 with the charitable mission of assisting fragile people affected by health issues. Since inception, the Eurêka Foundation has supported and financed meaningful health initiatives led by non-profit organisations such as ClubHouse France, Simon de Cyrène and ELA.

ARCHIMED HAS DIRECTLY MANAGED AND INVESTED IN OVER 80 HEALTHCARE COMPANIES REPRESENTING OVER €50 BILLION OF COMBINED VALUE

This article is from: